Proresolving actions of synthetic and natural protease inhibitors are mediated by annexin A1

Journal of Immunology

Volumn 196, Issue 4, 2016, Pages 1922-1932

  Vago, Juliana P ^a   Tavares, Luciana P ^a   Sugimoto, Michelle A ^a   Lima, Graziele Letícia N ^a   Galvaõ, Izabela ^a   De Caux, Thais R ^a   Ia, Lima ^a   Ribeiro, Ana Luíza C ^a   Carneiro, Fernanda S ^a   Nunes, Fernanda Freire C ^a   Pinho, Vanessa ^a   Perretti, Mauro ^b   Teixeira, Mauro M ^a   Sousa, Lirlandia P ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCINE; LEUKOCYTE ELASTASE; LIPOCORTIN 1; PROTEINASE INHIBITOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SIVELESTAT; SLPI PROTEIN, HUMAN; SULFONAMIDE;

ANALOGS AND DERIVATIVES; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; DRUG EFFECTS; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; INFLAMMATION; MALE; METABOLISM; MOUSE; NEUTROPHIL; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; ANNEXIN A1; APOPTOSIS; BLOTTING, WESTERN; FLOW CYTOMETRY; GLYCINE; HUMANS; INFLAMMATION; LEUKOCYTE ELASTASE; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NEUTROPHILS; PROTEASE INHIBITORS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SULFONAMIDES;

EID: 84958559468     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500886     Document Type: Article

References (58)

1. Medzhitov, R. 2010. Inflammation 2010: new adventures of an old flame. Cell 140: 771-776.
2. Henriksen, P. A. 2014. The potential of neutrophil elastase inhibitors as antiinflammatory therapies. Curr. Opin. Hematol. 21: 23-28.
3. Greene, C. M., and N. G. McElvaney. 2009. Proteases and antiproteases in chronic neutrophilic lung disease-relevance to drug discovery. Br. J. Pharmacol. 158: 1048-1058.
4. Mancek-Keber, M. 2014. Inflammation-mediating proteases: structure, function in (patho) physiology and inhibition. Protein Pept. Lett. 21: 1209-1229.
5. Sallenave, J. M. 2000. The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. Respir. Res. 1: 87-92.
6. Williams, S. E., T. I. Brown, A. Roghanian, and J. M. Sallenave. 2006. SLPI and elafin: one glove, many fingers. Clin. Sci. 110: 21-35.
7. Weldon, S., N. McGarry, C. C. Taggart, and N. G. McElvaney. 2007. The role of secretory leucoprotease inhibitor in the resolution of inflammatory responses. Biochem. Soc. Trans. 35: 273-276.
8. Norling, L. V., and C. N. Serhan. 2010. Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination. J. Intern. Med. 268: 15-24.
9. Serhan, C. N. 2014. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510: 92-101.
10. Dalli, J., and C. N. Serhan. 2012. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and proresolving mediators. Blood 120: e60-e72.
11. Sousa, L. P., A. L. Alessandri, V. Pinho, andM.M. Teixeira. 2013. Pharmacological strategies to resolve acute inflammation. Curr. Opin. Pharmacol. 13: 625-631.
12. Perretti, M., and F. D'Acquisto. 2009. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 9: 62-70.
13. Vong, L., F. D'Acquisto, M. Pederzoli-Ribeil, L. Lavagno, R. J. Flower, V. Witko-Sarsat, and M. Perretti. 2007. Annexin 1 cleavage in activated neutrophils: A pivotal role for proteinase 3. J. Biol. Chem. 282: 29998-30004.
14. Oliani, S. M., M. J. Paul-Clark, H. C. Christian, R. J. Flower, and M. Perretti. 2001. Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression. Am. J. Pathol. 158: 603-615.
15. Tsao, F. H., K. C. Meyer, X. Chen, N. S. Rosenthal, and J. Hu. 1998. Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 18: 120-128.
16. Williams, S. L., I. R. Milne, C. J. Bagley, J. R. Gamble, M. A. Vadas, S. M. Pitson, and Y. Khew-Goodall. 2010. A proinflammatory role for proteolytically cleaved annexin A1 in neutrophil transendothelial migration. J. Immunol. 185: 3057-3063.
17. Pederzoli-Ribeil, M., F. Maione, D. Cooper, A. Al-Kashi, J. Dalli, M. Perretti, and F. D'Acquisto. 2010. Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature. Blood 116: 4288-4296.
18. Patel, H. B., K. N. Kornerup, A. L. Sampaio, F. D'Acquisto, M. P. Seed, A. P. Girol, M. Gray, C. Pitzalis, S. M. Oliani, and M. Perretti. 2012. The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis. Ann. Rheum. Dis. 71: 1872-1880.
19. Dalli, J., A. P. Consalvo, V. Ray, C. Di Filippo, M. D'Amico, N. Mehta, and M. Perretti. 2013. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor. J. Immunol. 190: 6478-6487.
20. Gobbetti, T., S. M. Coldewey, J. Chen, S. McArthur, P. le Faouder, N. Cenac, R. J. Flower, C. Thiemermann, and M. Perretti. 2014. Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis. Proc. Natl. Acad. Sci. USA 111: 18685-18690.
21. Bannenberg, G. L., N. Chiang, A. Ariel, M. Arita, E. Tjonahen, K. H. Gotlinger, S. Hong, and C. N. Serhan. 2005. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174: 4345-4355.
22. Vago, J. P., C. R. Nogueira, L. P. Tavares, F. M. Soriani, F. Lopes, R. C. Russo, V. Pinho, M. M. Teixeira, and L. P. Sousa. 2012. Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis. J. Leukoc. Biol. 92: 249-258.
23. Sousa, L. P., F. Lopes, D. M. Silva, L. P. Tavares, A. T. Vieira, B. M. Rezende, A. F. Carmo, R. C. Russo, C. C. Garcia, C. A. Bonjardim, et al. 2010. PDE4 inhibition drives resolution of neutrophilic inflammation by inducing apoptosis in a PKA-PI3K/Akt-dependent and NF-kB-independent manner. J. Leukoc. Biol. 87: 895-904.
24. Amaral, F. A., V. V. Costa, L. D. Tavares, D. Sachs, F. M. Coelho, C. T. Fagundes, F. M. Soriani, T. N. Silveira, L. D. Cunha, D. S. Zamboni, et al. 2012. NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout. Arthritis Rheum. 64: 474-484.
25. Souza, D. G., C. T. Fagundes, F. A. Amaral, D. Cisalpino, L. P. Sousa, A. T. Vieira, V. Pinho, J. R. Nicoli, L. Q. Vieira, I. M. Fierro, and M. M. Teixeira. 2007. The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice. J. Immunol. 179: 8533-8543.
26. Vago, J. P., L. P. Tavares, C. C. Garcia, K. M. Lima, L. O. Perucci, E. L. Vieira, C. R. Nogueira, F. M. Soriani, J. O. Martins, P. M. Silva, et al. 2015. The role and effects of glucocorticoid-induced leucine zipper in the context of inflammation resolution. J. Immunol. 194: 4940-4950.
27. Schif-Zuck, S., N. Gross, S. Assi, R. Rostoker, C. N. Serhan, and A. Ariel. 2011. Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur. J. Immunol. 41: 366-379.
28. Lucas, C. D., K. C. Allen, D. A. Dorward, L. J. Hoodless, L. A. Melrose, J. A. Marwick, C. S. Tucker, C. Haslett, R. Duffin, and A. G. Rossi. 2013. Flavones induce neutrophil apoptosis by down-regulation of Mcl-1 via a proteasomal-dependent pathway. FASEB J. 27: 1084-1094.
29. Chiang, N., M. Shinohara, J. Dalli, V. Mirakaj, M. Kibi, A. M. Choi, and C. N. Serhan. 2013. Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits. J. Immunol. 190: 6378-6388.
30. Martinon, F., and L. H. Glimcher. 2006. Gout: new insights into an old disease. J. Clin. Invest. 116: 2073-2075.
31. Ariel, A., and C. N. Serhan. 2012. New lives given by cell death: macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation. Front. Immunol. 3: 4.
32. Perez, D. A., J. P. Vago, R. M. Athayde, A. C. Reis, M. M. Teixeira, L. P. Sousa, and V. Pinho. 2014. Switching off key signaling survival molecules to switch on the resolution of inflammation. Mediators Inflamm. 2014: 829851.
33. Turk, B. 2006. Targeting proteases: successes, failures and future prospects. Nat. Rev. Drug Discov. 5: 785-799.
34. Sallenave, J. M., J. Shulmann, J. Crossley, M. Jordana, and J. Gauldie. 1994. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastasespecific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am. J. Respir. Cell Mol. Biol. 11: 733-741.
35. Eisenberg, S. P., K. K. Hale, P. Heimdal, and R. C. Thompson. 1990. Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J. Biol. Chem. 265: 7976-7981.
36. Odaka, C., T. Mizuochi, J. Yang, and A. Ding. 2003. Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory response. J. Immunol. 171: 1507-1514.
37. Marino, R., T. Thuraisingam, P. Camateros, C. Kanagaratham, Y. Z. Xu, J. Henri, J. Yang, G. He, A. Ding, and D. Radzioch. 2011. Secretory leukocyte protease inhibitor plays an important role in the regulation of allergic asthma in mice. J. Immunol. 186: 4433-4442.
38. Reeves, E. P., N. Banville, D. M. Ryan, N. O'Reilly, D. A. Bergin, K. Pohl, K. Molloy, O. J. McElvaney, K. Alsaleh, A. Aljorfi, et al. 2013. Intracellular secretory leukoprotease inhibitor modulates inositol 1,4,5-triphosphate generation and exerts an anti-inflammatory effect on neutrophils of individuals with cystic fibrosis and chronic obstructive pulmonary disease. BioMed Res. Int. 2013: 560141.
39. Nakamura, A., Y. Mori, K. Hagiwara, T. Suzuki, T. Sakakibara, T. Kikuchi, T. Igarashi, M. Ebina, T. Abe, J. Miyazaki, et al. 2003. Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice. J. Exp. Med. 197: 669-674.
40. Shaw, L., and O.Wiedow. 2011. Therapeutic potential of human elafin. Biochem. Soc. Trans. 39: 1450-1454.
41. Sallenave, J. M., M. Si Tahar, G. Cox, M. Chignard, and J. Gauldie. 1997. Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils. J. Leukoc. Biol. 61: 695-702.
42. Mihaila, A., and G. M. Tremblay. 2001. Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor. Zeitschrift fur Naturforschung. C. J. Biosci. 56: 291-297.
43. Antoniades, C. G., W. Khamri, R. D. Abeles, L. S. Taams, E. Triantafyllou, L. A. Possamai, C. Bernsmeier, R. R. Mitry, A. O'Brien, D. Gilroy, et al. 2014. Secretory leukocyte protease inhibitor: A pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure. Hepatology 59: 1564-1576.
44. Kambe, M., R. Bessho, M. Fujii, M. Ochi, and K. Shimizu. 2009. Sivelestat reduces myocardial ischemia and reperfusion injury in rat hearts even when administered after onset of myocardial ischemia. Interact. Cardiovasc. Thorac. Surg. 8: 629-634.
45. Hayakawa, M., K. Katabami, T. Wada, M. Sugano, H. Hoshino, A. Sawamura, and S. Gando. 2010. Sivelestat (selective neutrophil elastase inhibitor) improves the mortality rate of sepsis associated with both acute respiratory distress syndrome and disseminated intravascular coagulation patients. Shock 33: 14-18.
46. Iba, T., A. Kidokoro, M. Fukunaga, K. Takuhiro, S. Yoshikawa, and K. Sugimotoa. 2006. Pretreatment of sivelestat sodium hydrate improves the lung microcirculation and alveolar damage in lipopolysaccharide-induced acute lung inflammation in hamsters. Shock 26: 95-98.
47. Yasui, S., A. Nagai, K. Aoshiba, Y. Ozawa, Y. Kakuta, and K. Konno. 1995. A specific neutrophil elastase inhibitor (ONO-5046.Na) attenuates LPS-induced acute lung inflammation in the hamster. Eur. Respir. J. 8: 1293-1299.
48. Rhen, T., and J. A. Cidlowski. 2005. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N. Engl. J. Med. 353: 1711-1723.
49. Yazid, S., G. Leoni, S. J. Getting, D. Cooper, E. Solito, M. Perretti, and R. J. Flower. 2010. Antiallergic cromones inhibit neutrophil recruitment onto vascular endothelium via annexin-A1 mobilization. Arterioscler. Thromb. Vasc. Biol. 30: 1718-1724.
50. Milot, E., and J. G. Filep. 2011. Regulation of neutrophil survival/apoptosis by Mcl-1. ScientificWorldJournal 11: 1948-1962.
51. Rossi, A. G., D. A. Sawatzky, A. Walker, C. Ward, T. A. Sheldrake, N. A. Riley, A. Caldicott, M. Martinez-Losa, T. R. Walker, R. Duffin, et al. 2006. Cyclindependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. [Published erratum appears in 2006 Nat. Med. 12: 1434.] Nat. Med. 12: 1056-1064.
52. El Kebir, D., L. József, W. Pan, L. Wang, N. A. Petasis, C. N. Serhan, and J. G. Filep. 2009. 15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury. Am. J. Respir. Crit. Care Med. 180: 311-319.
53. Serhan, C. N., S. D. Brain, C. D. Buckley, D. W. Gilroy, C. Haslett, L. A. O'Neill, M. Perretti, A. G. Rossi, and J. L. Wallace. 2007. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21: 325-332.
54. Korns, D., S. C. Frasch, R. Fernandez-Boyanapalli, P. M. Henson, and D. L. Bratton. 2011. Modulation of macrophage efferocytosis in inflammation. Front. Immunol. 2: 57.
55. Alessandri, A. L., L. P. Sousa, C. D. Lucas, A. G. Rossi, V. Pinho, and M. M. Teixeira. 2013. Resolution of inflammation: mechanisms and opportunity for drug development. Pharmacol. Ther. 139: 189-212.
56. Michlewska, S., I. Dransfield, I. L. Megson, and A. G. Rossi. 2009. Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-a. FASEB J. 23: 844-854.
57. Henriksen, P. A., A. Devitt, Y. Kotelevtsev, and J. M. Sallenave. 2004. Gene delivery of the elastase inhibitor elafin protects macrophages from neutrophil elastase-mediated impairment of apoptotic cell recognition. FEBS Lett. 574: 80-84.
58. Dalli, J., L. V. Norling, D. Renshaw, D. Cooper, K. Y. Leung, and M. Perretti. 2008. Annexin 1 mediates the rapid anti-inflammatory effects of neutrophilderived microparticles. Blood 112: 2512-2519.